Healthspan Capital

Healthspan Capital is a leading venture capital and private equity firm dedicated to investing in the burgeoning field of longevity biotechnology ("LongBio") and regenerative medicine. As one of the most active investors in the LongBio space in 2022-3, Healthspan Capital is committed to supporting early-stage companies that are pioneering groundbreaking advancements in extending healthy lifespans and combating age-related diseases.

Healthspan Capital focuses on identifying and nurturing innovative companies with the potential to revolutionize healthcare and improve the quality of life for individuals worldwide. By providing strategic funding and invaluable expertise, Healthspan Capital empowers its portfolio companies to accelerate their research, development, and commercialization efforts.

Healthspan Capital is positioned to drive significant progress in the longevity biotech sector. We invite the management team at Healthspan Capital to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.